James Michael Billingsley
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Simian immunodeficiency virus | 8 | 2018 | 846 | 0.990 |
Why?
|
| Viral Regulatory and Accessory Proteins | 2 | 2018 | 159 | 0.660 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 5 | 2018 | 570 | 0.570 |
Why?
|
| SAIDS Vaccines | 2 | 2015 | 166 | 0.490 |
Why?
|
| Growth Hormone-Releasing Hormone | 3 | 2021 | 213 | 0.390 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2018 | 4479 | 0.330 |
Why?
|
| Immunologic Memory | 3 | 2015 | 1348 | 0.330 |
Why?
|
| HIV Infections | 11 | 2022 | 16718 | 0.260 |
Why?
|
| Virus Replication | 6 | 2019 | 2534 | 0.260 |
Why?
|
| Macaca mulatta | 8 | 2019 | 2375 | 0.250 |
Why?
|
| Interleukin-15 | 2 | 2022 | 184 | 0.240 |
Why?
|
| Interferon-alpha | 2 | 2018 | 895 | 0.230 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2018 | 4386 | 0.190 |
Why?
|
| T-Lymphocytes, Cytotoxic | 4 | 2021 | 1821 | 0.180 |
Why?
|
| Viremia | 3 | 2018 | 736 | 0.170 |
Why?
|
| Growth Substances | 1 | 2021 | 784 | 0.170 |
Why?
|
| Lentiviruses, Primate | 1 | 2018 | 7 | 0.160 |
Why?
|
| Host Specificity | 1 | 2018 | 52 | 0.160 |
Why?
|
| Human Immunodeficiency Virus Proteins | 1 | 2018 | 65 | 0.160 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 1 | 2018 | 153 | 0.160 |
Why?
|
| Gene Products, env | 1 | 2018 | 263 | 0.150 |
Why?
|
| Gene Expression | 2 | 2020 | 7799 | 0.140 |
Why?
|
| Blood Proteins | 1 | 2021 | 1124 | 0.140 |
Why?
|
| HIV-1 | 5 | 2020 | 6939 | 0.130 |
Why?
|
| Lymphocyte Activation | 5 | 2018 | 5524 | 0.130 |
Why?
|
| Transcription Factors | 1 | 2015 | 12208 | 0.130 |
Why?
|
| Interferon Type I | 1 | 2018 | 542 | 0.120 |
Why?
|
| Th1 Cells | 1 | 2019 | 1057 | 0.120 |
Why?
|
| Adenoviridae | 1 | 2018 | 1099 | 0.120 |
Why?
|
| Receptors, IgE | 2 | 2005 | 389 | 0.110 |
Why?
|
| Th17 Cells | 1 | 2019 | 766 | 0.110 |
Why?
|
| Huntington Disease | 1 | 2019 | 1124 | 0.110 |
Why?
|
| Viral Load | 6 | 2019 | 3299 | 0.110 |
Why?
|
| Polyethylene Glycols | 1 | 2018 | 1182 | 0.110 |
Why?
|
| Pluripotent Stem Cells | 1 | 2019 | 795 | 0.110 |
Why?
|
| Astrocytes | 1 | 2019 | 1270 | 0.100 |
Why?
|
| Immunity, Cellular | 1 | 2018 | 1607 | 0.100 |
Why?
|
| Iron | 1 | 2020 | 1774 | 0.100 |
Why?
|
| T-Lymphocytes | 3 | 2018 | 10180 | 0.100 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 1708 | 0.100 |
Why?
|
| Receptors, CXCR5 | 2 | 2022 | 92 | 0.090 |
Why?
|
| Cell Differentiation | 2 | 2019 | 11483 | 0.090 |
Why?
|
| Interleukin-12 | 2 | 2022 | 579 | 0.090 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 3586 | 0.080 |
Why?
|
| Anti-Retroviral Agents | 1 | 2018 | 1715 | 0.080 |
Why?
|
| Genetic Vectors | 1 | 2018 | 3420 | 0.080 |
Why?
|
| Proteomics | 1 | 2021 | 3638 | 0.080 |
Why?
|
| Chromatin | 1 | 2019 | 2934 | 0.080 |
Why?
|
| Calcium Channels | 2 | 2007 | 622 | 0.070 |
Why?
|
| Placebos | 2 | 2021 | 1676 | 0.070 |
Why?
|
| Antiviral Agents | 1 | 2018 | 2987 | 0.070 |
Why?
|
| Ion Transport | 1 | 2006 | 320 | 0.070 |
Why?
|
| Anti-HIV Agents | 2 | 2019 | 4256 | 0.060 |
Why?
|
| Animals | 13 | 2021 | 168757 | 0.060 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2005 | 293 | 0.060 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 9438 | 0.050 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 1999 | 986 | 0.050 |
Why?
|
| Mast Cells | 2 | 2007 | 1544 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 2 | 2018 | 9274 | 0.050 |
Why?
|
| Killer Cells, Natural | 2 | 2022 | 2133 | 0.050 |
Why?
|
| Lymph Nodes | 2 | 2022 | 3474 | 0.050 |
Why?
|
| Multiprotein Complexes | 1 | 2006 | 1119 | 0.040 |
Why?
|
| Sumoylation | 1 | 2020 | 83 | 0.040 |
Why?
|
| Administration, Intravaginal | 1 | 2019 | 150 | 0.040 |
Why?
|
| E2F Transcription Factors | 1 | 2019 | 277 | 0.040 |
Why?
|
| Calcium | 3 | 2007 | 5756 | 0.040 |
Why?
|
| Immunoglobulin E | 1 | 2005 | 1463 | 0.040 |
Why?
|
| Sequence Alignment | 2 | 2018 | 2256 | 0.040 |
Why?
|
| Inflammation | 1 | 2018 | 10638 | 0.040 |
Why?
|
| Macaca | 1 | 2020 | 440 | 0.040 |
Why?
|
| Hepatitis | 1 | 2020 | 227 | 0.040 |
Why?
|
| Signal Transduction | 5 | 2019 | 23403 | 0.040 |
Why?
|
| Receptors, Interferon | 1 | 2018 | 115 | 0.040 |
Why?
|
| Oxidative Phosphorylation | 1 | 2020 | 481 | 0.040 |
Why?
|
| Growth Hormone | 1 | 2020 | 705 | 0.040 |
Why?
|
| Virus Latency | 1 | 2020 | 358 | 0.040 |
Why?
|
| Double-Blind Method | 2 | 2021 | 12026 | 0.040 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2021 | 644 | 0.040 |
Why?
|
| Hormones | 1 | 2020 | 889 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2006 | 5456 | 0.030 |
Why?
|
| Ki-67 Antigen | 1 | 2018 | 644 | 0.030 |
Why?
|
| Hypersensitivity | 1 | 2005 | 1102 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2019 | 1590 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2019 | 635 | 0.030 |
Why?
|
| Cells, Cultured | 3 | 2018 | 19229 | 0.030 |
Why?
|
| Jejunum | 1 | 2017 | 480 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2020 | 2187 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2005 | 4026 | 0.030 |
Why?
|
| Ligands | 1 | 2021 | 3282 | 0.030 |
Why?
|
| Virulence | 1 | 2018 | 1333 | 0.030 |
Why?
|
| Cell Communication | 1 | 2021 | 1621 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2006 | 3703 | 0.030 |
Why?
|
| Cell Line | 3 | 2020 | 15997 | 0.030 |
Why?
|
| Amino Acid Sequence | 3 | 2018 | 13815 | 0.030 |
Why?
|
| Homosexuality, Male | 1 | 2020 | 1240 | 0.030 |
Why?
|
| Neural Stem Cells | 1 | 2019 | 851 | 0.030 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2020 | 2015 | 0.030 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2014 | 442 | 0.030 |
Why?
|
| Female | 7 | 2021 | 380194 | 0.030 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2018 | 2559 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2020 | 2012 | 0.030 |
Why?
|
| Cell Survival | 1 | 2021 | 5882 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 18029 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2020 | 4217 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2021 | 10481 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2021 | 2725 | 0.020 |
Why?
|
| Tyrosine | 2 | 2005 | 1461 | 0.020 |
Why?
|
| Humans | 15 | 2022 | 744343 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2021 | 3508 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2006 | 7880 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2018 | 2499 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 12072 | 0.020 |
Why?
|
| Cell Movement | 1 | 2021 | 5217 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2019 | 2948 | 0.020 |
Why?
|
| Gene Products, gag | 2 | 1999 | 337 | 0.020 |
Why?
|
| HIV Core Protein p24 | 2 | 1999 | 256 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 6622 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2020 | 2214 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2020 | 8324 | 0.020 |
Why?
|
| Cell Degranulation | 1 | 2007 | 287 | 0.020 |
Why?
|
| Chronic Disease | 2 | 2018 | 9146 | 0.020 |
Why?
|
| Vaccination | 1 | 2018 | 3278 | 0.020 |
Why?
|
| Passive Cutaneous Anaphylaxis | 1 | 2005 | 35 | 0.020 |
Why?
|
| Vitronectin | 1 | 2005 | 44 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2017 | 2958 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2014 | 2866 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2018 | 4665 | 0.020 |
Why?
|
| Liver | 1 | 2020 | 7474 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 4253 | 0.020 |
Why?
|
| Protein Kinase C-delta | 1 | 2005 | 123 | 0.020 |
Why?
|
| Enzyme Precursors | 1 | 2004 | 176 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 9959 | 0.020 |
Why?
|
| U937 Cells | 1 | 2004 | 268 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2007 | 959 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2006 | 905 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 2006 | 964 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2018 | 7722 | 0.010 |
Why?
|
| Young Adult | 2 | 2021 | 56430 | 0.010 |
Why?
|
| Glutamine | 1 | 2006 | 578 | 0.010 |
Why?
|
| Phosphorylation | 2 | 2005 | 8436 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 21827 | 0.010 |
Why?
|
| Male | 5 | 2021 | 350118 | 0.010 |
Why?
|
| Melanoma | 1 | 2021 | 5510 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2007 | 2008 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2004 | 936 | 0.010 |
Why?
|
| src-Family Kinases | 1 | 2004 | 551 | 0.010 |
Why?
|
| Cell Division | 2 | 1999 | 4568 | 0.010 |
Why?
|
| Fibrinogen | 1 | 2005 | 894 | 0.010 |
Why?
|
| Fibronectins | 1 | 2005 | 726 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 2006 | 1169 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2006 | 4320 | 0.010 |
Why?
|
| Serotonin | 1 | 2005 | 1017 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2005 | 1227 | 0.010 |
Why?
|
| Prognosis | 1 | 2020 | 29063 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 2006 | 18111 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2006 | 3846 | 0.010 |
Why?
|
| Mice | 2 | 2021 | 81183 | 0.010 |
Why?
|
| HLA-A2 Antigen | 1 | 1999 | 213 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2006 | 5179 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2005 | 3144 | 0.010 |
Why?
|
| HIV Envelope Protein gp160 | 1 | 1997 | 99 | 0.010 |
Why?
|
| Adult | 3 | 2021 | 214055 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 1999 | 758 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2006 | 2564 | 0.010 |
Why?
|
| Middle Aged | 2 | 2021 | 213383 | 0.010 |
Why?
|
| Major Histocompatibility Complex | 1 | 1999 | 936 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2005 | 2440 | 0.010 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 1999 | 880 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2004 | 2455 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 1999 | 1850 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2005 | 2916 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2004 | 2915 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1997 | 1369 | 0.010 |
Why?
|
| Chemokines | 1 | 1997 | 970 | 0.010 |
Why?
|
| Adolescent | 1 | 2021 | 85781 | 0.010 |
Why?
|
| Cytokines | 1 | 2007 | 7322 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2007 | 14557 | 0.010 |
Why?
|
| HIV Antibodies | 1 | 1999 | 1322 | 0.010 |
Why?
|
| Disease Progression | 2 | 1999 | 13284 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1999 | 2617 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 1997 | 3206 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 163280 | 0.010 |
Why?
|
| Rats | 1 | 2005 | 24260 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1997 | 6489 | 0.000 |
Why?
|
| Peptides | 1 | 1999 | 4409 | 0.000 |
Why?
|
| Cohort Studies | 2 | 1999 | 40561 | 0.000 |
Why?
|
| Peptide Fragments | 1 | 1997 | 5097 | 0.000 |
Why?
|
| Longitudinal Studies | 1 | 1999 | 13989 | 0.000 |
Why?
|
| Phenotype | 1 | 1999 | 16365 | 0.000 |
Why?
|
| Time Factors | 1 | 1999 | 40075 | 0.000 |
Why?
|
| Mutation | 1 | 1999 | 29786 | 0.000 |
Why?
|